Introduction
Acetylcholinesterase (AChE, EC 3.1.1.7) is a carboxylesterase that plays an essential role in acetylcholinemediated neurotransmission. AChE transcripts are classified into R, H, and T transcripts, which are formed by alternative splicing of a single gene in vertebrates [1] . AChE-T is expressed in muscles and the nervous system; therefore, it represents the functional cholinesterase species in the cholinergic system [2, 3] . AChE-T is also referred to as AChE-S (synaptic) [4] .
Besides the function of hydrolyzing acetylcholine, AChE has been reported to perform other non-catalytic roles [5] , such as promoting cell adhesion and neurite outgrowth [6] , amyloidosis [7] , and apoptosis [8] .
In our previous study, the induction of apoptosis by various stimuli led to the expression of AChE-S in various cells [8] . After the cell has committed to apoptosis, AChE first appears in the cytoplasm followed by its appearance in the nucleus or the apoptotic bodies [8, 9] . The blockage of AChE expression by antisense or the inhibition of AChE activity by pharmacological inhibitors can prevent the induction of apoptosis [8] , suggesting that AChE expression is not just a consequence of apoptosis. Moreover, the silencing of the AChE gene by siRNA indicated that AChE may play a critical role in the apoptosome [10] . However, the function of AChE has not been elucidated.
Interactions of AChE with a number of proteins and peptides have been reported, including laminin [11] [12] [13] , collagen IV [11] , the nicotinic acetylcholine receptor [14] , the RACK1 [15] , the C-terminal binding protein (CtBP) [16] , and the amyloid b-peptide (Ab) [17] . Laminin or collagen IV was found to bind AChE on or near the site of the peripheral anionic site (PAS) of AChE [11] [12] [13] . PAS is a specific motif, located close to the rim of the active-site gorge of the enzyme. Laminin and collagen IV are the most abundant components of the basement membrane (BM) and it is well documented that BM components promote cell migration and neurite outgrowth [18] , so the interaction between AChE and laminin or collagen IV has the possible roles in neurite outgrowth and synaptogenesis. An AChE-peptide derived from the C-terminus of AChE, a novel nicotinic acetylcholine receptor ligand, is bioactive in a ligand-specific and concentration-dependent manner [14] . The nanomolar pathophysiological concentrations of AChE-peptide induce neuronal damage via a predominantly apoptotic mechanism involving a7 nicotinic AChR (nAChR) activation [19, 20] . The scaffold protein the receptor for activated C kinase 1 (RACK1) interacts with the C-terminal domain unique to AChE-R (different from the C-terminal domain of AChE-S) [15, 21, 22] . AChE-R correlates with intensified fear-induced conflict behavior through AChE-R/RACK1/PKC bII complexes [15] and has a genotoxic resistance by competing with endogenous RACK1 for p73 interaction [22] . The binding of CtBP to the C-terminal of AChE-S can modify Ikaros functions, thereby causing T lymphopenia [16] . Ab interacts with AChE on the site of V-loop located in the vicinity of the PAS of AChE, which promotes Ab fibril formation [17] .
Butyrylcholinesterase (BChE; EC 3.1.1.8) is homologous to AChE, and compensates, to some degree, for the lack of AChE in synapses and neuromuscular junctions. BChE lacks the peripheral site (PAS) which has been shown to be significant in the non-synaptic functions of AChE [23] . Although BChE is closely homologous to AChE (70% identity), it does not promote cell adhesion [24, 25] . It does not bind laminin in vitro [11] , nor does this protein dock with Gas6, the ligand for Mer. BChEpeptide, at lower concentrations, had little physiological effects on endogenously expressed a7 nAChR [14] . The BChE gene is amplified or abnormally expressed in tumorigenesis and some neuronal disorders, and the suppression of BChE increases the rate of cell death [25] . However, the blockage of AChE expression can prevent the induction of apoptosis [8] . So BChE is unlikely to replace AChE in neurite outgrowth, amyloidosis, and apoptosis.
To study the mechanisms of AChE during apoptosis, we used a yeast two-hybrid system to identify the proteins that interact with AChE. Ran-binding protein in the microtubule-organizing center (RanBPM) was originally identified in a yeast two hybrid searching for novel binding partners of Ran GTPase [26] . RanBPM is a multi-domain intracellular protein that has been found to act as a scaffold for certain tyrosine kinases [27, 28] , adhesion receptors [29, 30] , and nuclear-signaling proteins [31, 32] . However, unlike most other identified Ran-binding proteins, RanBPM is not involved in nuclear-cytoplasmic transport [33, 34] .
In this article, we established that RanBPM is an AChE-interacting protein that is translocated from the cytoplasm into the nucleus during apoptosis, similar to the translocation of AChE.
Materials and Methods
Plasmid construction pACT2-RanBPM was isolated from a human fetal brain matchmaker cDNA library (Clontech, Mountain View, USA) by yeast two-hybrid. HA-RanBPM or MycRanBPM was constructed by transferring RanBPM insert from pACT2-RanBPM into a pCMV-HA (Clontech) or pCMV-Myc vector (Clontech) by SfiI and XhoI digestion. In addition, pcDNA3-Myc-AChE C-terminal was constructed by transferring the C-terminus of human AChE to pcDNA3-Myc (derived from pcDNA3.0, Invitrogen, Carlsbad, USA) by EcoRI and BamHI digestion. pcDNA3-Myc-AChE was constructed by transferring human AChE to pcDNA3-Myc (derived from pcDNA3.0, Invitrogen) by EcoRI and BamHI digestion. pEGFP-C1-AChE was constructed by transferring human AChE to pEGFP-C1 (Clontech) by BglII and EcoRI digestion. All the constructs were verified by DNA sequencing.
Yeast two-hybrid screening Yeast two-hybrid screening was performed using a matchmaker GAL4 two-hybrid system 3 (Clontech) according to the manufacturer's instructions. A 159-bp fragment coding for 54 amino acids of the C-terminus of human AChE (AChE C-terminal ) was fused to the GAL4-DNA-binding domain of the pGBKT7 vector (Clontech). The human fetal brain matchmaker cDNA library (Clontech) was screened. To confirm the interaction, the rescued library plasmid of the positive clone was cotransfected along with the bait plasmid into yeast and analyzed by liquid culture assay with chloropheno red-b-D-galactopyranoside as a substrate.
Cell culture, transfection, and drug treatment HEK293T cells (Catalog, No. GNHu17) were cultured in DMEM supplemented with 10% fetal bovine serum at 378C in a 5% CO 2 atmosphere. Torriglia's long-term culture method was employed to induce apoptosis in HEK392T cell [35] . Briefly, cells were maintained for up to 8 days without medium change at a density of 1 Â 10 5 cells/ml. Then, the cells were transfected using a calcium-phosphate-mediated transfection method [36] . After transfection, 30 mg/ml cisplatin (Sigma, St. Louis, USA) in DMSO was added directly to the cell medium at the final concentration of 200 mM, and the cells were incubated for 24 h.
DNA-ladder-formation assay
The cells were disrupted in lysis buffer (5 mM Tris, 20 mM EDTA, pH 8.0) on ice for 30 min followed by centrifugation (16,000 g, 48C, 20 min). The supernatant was collected and proteinase K (50 mg/ml) and RNase A (40 mg/ml) were added. After incubation for 1 h at 378C, DNA was extracted by adding the same volume of phenol/chloroform. After shaking and centrifugation, the upper phase was collected. Then, one-tenth volume of 3 M sodium acetate ( pH 5.2) and two volumes of ice-cold (2208C) ethanol were added, and the samples were incubated overnight at 2208C. After centrifugation (16,000 g, 48C, 30 min), the pellet was dissolved in TE buffer. DNA was analyzed in 1.5% agarose gel.
MTT staining
Cells were seeded into 96-well plates (1 Â 10 4 cells/ well) in triplicate and grown for 18 h. Then, the cells were exposed to various concentrations (50, 100, 200 mM) of cisplatin for 24 h. After 24-h cisplatin treatment, 20 ml of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (0.5 mg/ml) was added along with 200 ml of medium into each well. The resulting cells were incubated for 3 h at 378C, and the converted dye was solubilized with acidic isopropanol (0.04-0.1 M HCl in absolute isopropanol). The absorbance of the converted dye was measured at 570 nm, with background subtraction at 630 nm.
Co-immunoprecipitation and immunoblotting
Cells were lysed in lysis buffer (150 mM NaCl, 25 mM Tris-HCl, pH 7.4, 0.2 mM PMSF, 2 mM EDTA, 0.5% Triton X-100) on ice for 30 min followed by centrifugation (12,000 g, 48C, 30 min). Since AChE is expressed during ischemia/reperfusion (I/R)-induced apoptosis in vivo [37] , the kidney tissues of male Sprague-Dawley rats used as ischemia/reperfusion injury models [37] were homogenized in lysis buffer with complete protease inhibitors mixture (Roche Applied Science) for 30 min on ice. Then, 1 mg of the total lysate was precleared with protein A-Sepharose for 1 h at 48C and coimmunoprecipitated with 2 mg of antibody for 2 h. Then, protein A-Sepharose was added, and the mixture was incubated for an additional 1 h at 48C. The beads were washed three times with the lysis buffer. Immunoprecipitations were performed using the following antibodies: anti-Myc antibody (Cell Signalling, #2276), anti-AChE antibody (E70, the antibody against the N-terminal peptide GPVSAFLGIPFAEC was prepared in the rabbit [37] ), and anti-rabbit IgG antibody (Pierce, No. 31210). The immunoblots were processed as described previously [8] . The primary antibodies used were as follows: anti-RanBPM antibody (NB100-1281; Novus Biologicals) (1:1000), anti-AChE antibody (the antibody against AChE was prepared in the rabbit [37] ) (1:1000), anti-Myc antibody (1:5000), anti-AChE antibody (1:1000), anti-GFP antibody (sc-9996; Santa Cruz) (1:1000), anti-HA antibody (sc-805; Santa Cruz) (1:500), anti-caspase 3 antibody (Cell Signalling, #9662) (1:500), anti-histone 3 antibody (ab1791; ABCAM) (1:3000), anti-tubulin antibody (T6074; Sigma) (1:5000), anti-actin antibody (A5441; Sigma) (1:5000). The blots were developed using the ECL chemiluminescence kit (Amersham Biosciences).
Cytoplasmic and nuclear protein extraction
The nuclear extract and the cytoplasmic fraction of the cells were obtained by using NE-PER TM nuclear and cytoplasmic extraction kit (Pierce, #78833).
Immunofluorescence
The adherent cells were washed with cold phosphatebuffered saline (PBS) twice, and fixed in a paraformaldehyde solution (4% in PBS, pH 7.4) for 30 min at 48C. The cultures were subsequently washed twice with PBS, treated with permeabilization solution (0.1% Triton X-100 in 0.1% sodium citrate) on ice for 2 min, and incubated in blocking buffer (3% BSA in TBST) for 1 h. Then, the cells were incubated with the anti-Myc antibody (1:100) in TBST containing 3% BSA overnight at 48C. After incubation, the cells were washed and incubated with the secondary antibody Rhodamineconjugated anti-mouse IgG-R (Santa Cruz) (1:100) in the dark at 378C for 1 h. After washing, the cells were incubated in 2 mg/ml Hoechst33258 for 10 min at 378C in the dark, and then observed under a fluorescence microscope.
Semi-quantitative RT -PCR
Total RNA was extracted from the cells or rat tissues using TRIzol reagent (Invitrogen) and was reverse transcribed using M-MLV reverse transcriptase (RT) (Promega, Madison, USA). The resulting cDNAs were used as templates to amplify RanBPM (539 bp) ( Fig. 1(C) ]. The interaction between AChE C-terminal and RanBPM was reconfirmed by liquid b-galactosidase assay [ Fig. 1(D) ]. The result of liquid b-galactosidase showed that comparing with the positive control, the affinity is weaker, but stronger than the negative control.
Coimmunoprecipitation analysis was performed to confirm the interaction between RanBPM and AChE C-terminal . As shown in Fig. 1(E) , HA-RanBPM coimmunoprecipitated with Myc-AChE C-terminal , as well as with Myc-AChE [ Fig. 1(F) ].
Since RanBPM is conserved in mammals [34] , we used the kidney tissues of a rat model of ischemia/reperfusion injury to investigate the interaction between endogenous RanBPM and endogenous AChE. Endogenous RanBPM was found to be able to coimmunoprecipitate with endogenous AChE, in comparison with the findings for an unrelated control antibody [ Fig. 1(G) ]. Thus, RanBPM was identified as a protein partner of AChE-S.
Ubiquitous expression of RanBPM in normal rat tissues and human cell lines
The RanBPM mRNA was extracted from different rat tissues (brain, kidney, heart, liver, lung, ovary, pancreas, muscle, spleen, testis, uterus, and epididymis) or human cell lines (HeLa, HepG2, K562, 7721, and HEK293T) and detected by RT -PCR. As shown in Fig. 2 , RanBPM was widely expressed in various rat tissues and human cell lines.
Subcellular distribution of RanBPM and AChE
To examine the subcellular location of RanBPM and AChE, HEK293T cells were transfected with the expression plasmids mentioned in a previous section. As shown in Fig. 3(A,B) , HA-RanBPM and Myc-AChE C-terminal (or Myc-AChE) were detected in the cytoplasm. The results of the indirect immunofluorescent staining, which showed that Myc-RanBPM and GFP-AChE were clearly co-localized in the cytoplasm [ Fig. 3(C) ], were consistent with those of the western blot analysis.
Subcellular distribution of RanBPM and AChE after cisplatin treatment
HEK293T cells were incubated with various doses of cisplatin, and their viability was determined using the MTT assay. The results revealed that cisplatin at concentration from 50 to 200 mM caused moderate cytotoxicity to cultured HEK293T cells [ Fig. 4(A) ]. The total mRNA was extracted from HEK293T cells that treated with or without cisplatin, and detected by RT-PCR. As shown in Fig. 4(B) , compared with HEK293T cells without cisplatin treatment, the transcription level of p73a gene was increased after cisplatin treatment. One hallmark of apoptosis is the formation of DNA ladders. Therefore, we investigated this aspect. It was found that cisplatin at concentrations of 100 and 200 mM caused fragmentation of nuclear DNA [ Fig. 4(C) ]. Since cisplatin at concentrations of 100 and 200 mM elicited a marked decrease in cell survival, we selected the 200-mM cisplatin as the apoptosis inducer.
HEK293T cells co-expressing GFP-AChE and Myc-RanBPM were treated with or without cisplatin and fractionated into nuclear and cytoplasmic fractions. At the same levels of exogenous protein expression, the amounts of Myc-RanBPM and GFP-AChE in the nuclear fractions of the cells that had undergone cisplatin treatment were both clearly higher than those in the cells that did not undergo cisplatin treatment [ Fig. 4(D) ]. In conclusion, the amounts of AChE and RanBPM in the nuclear fractions increased after cisplatin treatment.
Nuclear distribution of endogenous RanBPM and AChE after long-term culture HEK293T cells were incubated for indicated time without medium change, and the occurrence of apoptosis was determined by cleaved caspase 3. Our results revealed that cleaved caspase 3 could be detected at the third day and was obvious at the seventh day [ Fig. 5(A) ]. HEK293T cells in long-term culture were fractionated into nuclear fractions. As shown in Fig. 5(B) , the amounts of endogenous RanBPM and endogenous AChE in the nuclear fractions of the cells that had undergone apoptosis were both clearly higher than those in the cells that did not undergo apoptosis.
Discussion
AChE-T has a 40-or 41-aa C-terminal peptide that is extremely well conserved in all vertebrates. It has been reported that a synthesized AChE-peptide from the C-terminal region induced neuronal cell death [19] . To identify the interacting proteins that are involved in apoptosis mediated by AChE-S, we employed the human AChE-S C terminus, which had no self-transcription activity [ Fig. 1(A) ], to screen the human fetal brain library. Here, we identified RanBPM as an AChE-interacting protein (Fig. 1) .
RanBPM is a highly conserved protein (Fig. 3) , which has already been shown in other studies. RanBPM is ubiquitously expressed in all analyzed tissues, including different brain regions, and cell lines [34, 38] . Within the brain, RanBPM occurs in the cortex, cerebellum, amygdala, hippocampus, and thalamus [39, 40] .
On the subcellular level, RanBPM can be found in the cytoplasm, the nucleus and the plasma membrane [34, 41] ; however, several studies have shown that endogenous RanBPM is primarily localized in the cytoplasm and membranes of the cells and does not appear to be present in the nucleus [29, 42, 43] . It can be speculated that there are different RanBPM complexes in different cellular environments such as the cell plasma membrane, cytosol, and nucleus. RanBPM was originally identified as a Ran GTPase-binding protein [26] . Unlike most other identified Ran-binding proteins, RanBPM does not contain the consensus Ran-binding domain [33] , a finding that is consistent with its lack of involvement in nuclear-cytoplasmic transport [34] . The results of analysis with the bioinformatics program PSORTII [44] suggest that RanBPM shows no nuclearlocalization signals (NLSs) and predict that RanBPM has a higher possibility of being cytoplasmic rather than nuclear, since the basic residue content calculated by PSORT was 7.7%. In our study, separate or synchronous expression of AChE and RanBPM corresponded to the detection of the two proteins in the cytoplasm (Fig. 4) .
Cisplatin is a widely used chemotherapeutic agent that is generally recognized as a DNA-damaging drug. AChE was induced in various cell types by different apoptotic stimuli [8, 45] . In HEK293T cells, p53 is inactivated by the SV40 T antigen. Despite the lack of p53 response, HEK293T cells succumbed to cisplatin treatment [46] . However, as shown in Fig. 4(A,C) , a higher concentration of cisplatin was needed to induce this response.
RanBPM can stabilize the levels of p73a which can modulate the cellular proteins/pathways that specifically regulate nuclear import and export of RanBPM [43] . p73 is an identified p53-related nuclear transcription factor that promotes cell arrest or apoptosis [47] , and it is significantly induced at the protein level in response to certain genotoxic stresses, including cisplatin treatment. This induction is mediated by a nuclear non-receptor tyrosine kinase c-Abl [48] [49] [50] . The transcription level of p73a gene was increased after cisplatin treatment [ Fig. 4(B) ]. As shown in Fig. 4(D) , the quantity of RanBPM in the nuclear fraction increased after cisplatin treatment.
Our previous studies using morphologic methods showed that the AChE protein was present in the cytoplasm at the initiation of apoptosis and in the nucleus or apoptotic bodies upon commitment to cell death [8, 51] . In living normal rat kidney (AChE over-expressing) cells, AChE protein was detected in the cytoplasm, but not in the nucleus; however, in the apoptotic cells, it was detected both in the cytoplasm and nucleus [9] . Coincident with the data from our previous studies, the quantity of AChE in the nuclear fraction increased after cisplatin treatment [ Fig. 4(D) ].
Myc-RanBPM and GFP-AChE were expressed under the P CMV IE promoter (cytomegalovirus immediate-early promoter) in order to check the subcellular localization of the two proteins during apoptosis. The activity of the P CMV IE promoter was different during the differentiation of embryonic stem cells into neurons [52] . So it was possible that the activity of P CMV IE promoter could be different between normal cells and apoptotic cells, and apoptosis-induced increases of both Myc-RanBPM and GFP-AChE in nuclear fractions could likely reflect changes in the efficacy of the CMV promoter. To exclude the possibility influence of changes caused by the activity of P CMV IE promoter, we checked the endogenous expression of AChE and RanBPM in the nuclear fractions in long-term HEK293T cultures. As shown in Fig. 5 , the amounts of endogenous AChE and endogenous RanBPM in the nuclear fractions were increased after long-term culture, which was coincident with the result from co-expressed exogenous Myc-RanBPM and GFP-AChE in HEK293T after cisplatin treatment [ Fig. 4(D) ].
The subcellular localization of AChE-S was investigated using the bioinformatics program PSORTII [44] . There were no NLSs for the AChE protein. AChE was considered to have a higher possibility of being cytoplasmic than nuclear, since the basic-residue content calculated by PSORT was 8.6%. A protein without its own NLS may enter the nucleus via cotransport with another protein that has an NLS. Since both AChE and RanBPM have no NLSs, we deduced that there was no obviously direct relationship between their translocations from the cytoplasm to the nucleus during apoptosis (data not shown). As RanBPM was associated with several proteins and composed a large protein complex [41] , it was possible that AChE and RanBPM composed a large protein complex with some protein that has an NLS.
In conclusion, RanBPM is an AChE-interacting protein that enters into the nucleus during apoptosis, similar to the translocation observed in case of AChE.
